| HGNC Family | Endogenous ligands |
| Name | neuropeptide Y |
| Description | This gene encodes a neuropeptide that is widely expressed in the central nervous system and influences many physiological processes, including cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular function. The neuropeptide functions through G protein-coupled receptors to inhibit adenylyl cyclase, activate mitogen-activated protein kinase (MAPK), regulate intracellular calcium levels, and activate potassium channels. A polymorphism in this gene resulting in a change of leucine 7 to proline in the signal peptide is associated with elevated cholesterol levels, higher alcohol consumption, and may be a risk factor for various metabolic and cardiovascular diseases. The protein also exhibits antimicrobial activity against bacteria and fungi. [provided by RefSeq, Oct 2014] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNeuropeptide Y (NPY) is a multifunctional peptide that plays a pivotal role in regulating stress‐related and neuropsychiatric processes. A number of genetic studies have demonstrated that natural variation in the NPY gene influences stress responsiveness, emotional regulation, and risk for psychiatric disorders. For example, functional polymorphisms affecting NPY expression have been linked to altered amygdala activation, anxiety, panic disorder, and even predisposition toward alcohol misuse and attention‐deficit disorders. In addition, NPY released in key brain regions such as the limbic system and non‐preganglionic Edinger–Westphal nucleus helps mediate adaptive responses to stress and may bolster resilience through its anxiolytic actions and modulation of reward circuits."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn parallel, NPY is a central mediator of metabolic balance and feeding behavior. Its widespread expression along the gut–brain axis and within distinct hypothalamic nuclei (including the arcuate and dorsomedial regions) enables NPY to integrate peripheral energy signals such as leptin, insulin, and ghrelin. These interactions govern not only food intake and energy expenditure but also influence body weight regulation, with genetic and epigenetic modifications in the NPY gene being associated with obesity traits, altered glucose homeostasis, and even responses to dietary interventions. Complementary studies have highlighted the involvement of NPY in modulating ionic channels in orexigenic neurons and its colocalization with other appetite‐regulating peptides, emphasizing its key role as an integrative metabolic sensor."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central neuromodulatory and metabolic roles, NPY also influences peripheral systems that contribute to cardiovascular regulation, immune responses, and cell survival. It contributes to vasoconstriction during cold‐induced sympathetic activation, participates in the modulation of atherosclerotic processes, and can affect tumor cell behavior by modulating receptor‐mediated signaling in cancers such as prostate cancer and neuroblastoma. Furthermore, proteolytic processing of NPY in circulation can modify its receptor binding profile, thereby altering its functional output in contexts as diverse as arrhythmogenesis during myocardial infarction, neuroinflammation in neurodegenerative disorders (including Alzheimer’s disease), and even immune cell migration and polarization in conditions like vitiligo and chronic pain syndromes. Collectively, these findings underscore the “many faces” of NPY as a master regulator in both central and peripheral physiology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "E Ilveskoski, O A Kajander, T Lehtimäki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of neuropeptide y polymorphism with the occurrence of type 1 and type 2 alcoholism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00000374-200110000-00003"}], "href": "https://doi.org/10.1097/00000374-200110000-00003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11696660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11696660"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jaakko Lappalainen, Henry R Kranzler, Robert Malison, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Gen Psychiatry (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/archpsyc.59.9.825"}], "href": "https://doi.org/10.1001/archpsyc.59.9.825"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12215082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12215082"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Guanshan Zhu, Lotta Pollak, Salim Mottagui-Tabar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.ALC.0000050642.62233.44"}], "href": "https://doi.org/10.1097/01.ALC.0000050642.62233.44"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12544000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12544000"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Masanari Itokawa, Makoto Arai, Shuhei Kato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0304-3940(03)00718-3"}], "href": "https://doi.org/10.1016/s0304-3940(03"}, {"type": "t", "text": "00718-3) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12875921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12875921"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kenji Ikeda, Kazuhiko Ikeda, Shuji Iritani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prog Neuropsychopharmacol Biol Psychiatry (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pnpbp.2003.11.008"}], "href": "https://doi.org/10.1016/j.pnpbp.2003.11.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14751436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14751436"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Salim Mottagui-Tabar, Jonathan A Prince, Claes Wahlestedt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.alc.0000164365.04961.b1"}], "href": "https://doi.org/10.1097/01.alc.0000164365.04961.b1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15897713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15897713"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Balázs Gaszner, Anikó Korosi, Miklós Palkovits, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Comp Neurol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cne.21177"}], "href": "https://doi.org/10.1002/cne.21177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17154253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17154253"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Katharina Domschke, Christa Hohoff, Christian Jacob, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet B Neuropsychiatr Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.b.30629"}], "href": "https://doi.org/10.1002/ajmg.b.30629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17948870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17948870"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zhifeng Zhou, Guanshan Zhu, Ahmad R Hariri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in human NPY expression affects stress response and emotion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature06858"}], "href": "https://doi.org/10.1038/nature06858"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18385673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18385673"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Leah Wetherill, Marc A Schuckit, Victor Hesselbrock, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alcohol Clin Exp Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1530-0277.2008.00790.x"}], "href": "https://doi.org/10.1111/j.1530-0277.2008.00790.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18828811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18828811"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Louise K Sjöholm, Leena Kovanen, Sirkku T Saarikoski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CLOCK is suggested to associate with comorbid alcohol use and depressive disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Circadian Rhythms (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1740-3391-8-1"}], "href": "https://doi.org/10.1186/1740-3391-8-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20180986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20180986"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "K-P Lesch, S Selch, T J Renner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2010.29"}], "href": "https://doi.org/10.1038/mp.2010.29"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20308990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20308990"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Wolfgang H Sommer, Jessica Lidström, Hui Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.21299"}], "href": "https://doi.org/10.1002/humu.21299"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20648632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20648632"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Stephanie H Witt, Arlette F Buchmann, Dorothea Blomeyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychoneuroendocrinology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psyneuen.2010.12.015"}], "href": "https://doi.org/10.1016/j.psyneuen.2010.12.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21273004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21273004"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "V S Mattevi, V M Zembrzuski, M H Hutz "}, {"type": "b", "children": [{"type": "t", "text": "Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Obes Relat Metab Disord (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.ijo.0802067"}], "href": "https://doi.org/10.1038/sj.ijo.0802067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12187394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12187394"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Bo Ding, Björn Kull, Zhurong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2004.10.011"}], "href": "https://doi.org/10.1016/j.regpep.2004.10.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15680469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15680469"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "S Nordman, B Ding, C-G Ostenson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Clin Endocrinol Diabetes (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/s-2005-865650"}], "href": "https://doi.org/10.1055/s-2005-865650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15926114"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15926114"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Boguslawa Baranowska, Ewa Wolińska-Witort, L Martyńska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuro Endocrinol Lett (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16135994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16135994"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Judit Menyhért, Gábor Wittmann, Ronald M Lechan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cocaine- and amphetamine-regulated transcript (CART) is colocalized with the orexigenic neuropeptide Y and agouti-related protein and absent from the anorexigenic alpha-melanocyte-stimulating hormone neurons in the infundibular nucleus of the human hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2007-0390"}], "href": "https://doi.org/10.1210/en.2007-0390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17525122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17525122"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jens Aberle, Jörg Flitsch, Nicola Alessia Beck, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2008.07.008"}], "href": "https://doi.org/10.1016/j.ymgme.2008.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18815063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18815063"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Troy A Roepke, Jian Qiu, Arik W Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fasting and 17β-estradiol differentially modulate the M-current in neuropeptide Y neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.1395-11.2011"}], "href": "https://doi.org/10.1523/JNEUROSCI.1395-11.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21849543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21849543"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Peter Holzer, Florian Reichmann, Aitak Farzi "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2012.08.005"}], "href": "https://doi.org/10.1016/j.npep.2012.08.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22979996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22979996"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sheng Bi, Yonwook J Kim, Fenping Zheng "}, {"type": "b", "children": [{"type": "t", "text": "Dorsomedial hypothalamic NPY and energy balance control."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2012.09.002"}], "href": "https://doi.org/10.1016/j.npep.2012.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23083763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23083763"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Daisuke Kohno, Toshihiko Yada "}, {"type": "b", "children": [{"type": "t", "text": "Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2012.09.004"}], "href": "https://doi.org/10.1016/j.npep.2012.09.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23107365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23107365"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ana B Crujeiras, Javier Campion, Angel Díaz-Lagares, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2013.06.012"}], "href": "https://doi.org/10.1016/j.regpep.2013.06.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23831408"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23831408"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "M K Karvonen, V P Valkonen, T A Lakka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0021-9150(01)00468-3"}], "href": "https://doi.org/10.1016/s0021-9150(01"}, {"type": "t", "text": "00468-3) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11689216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11689216"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Dan P Stephens, Adham R Saad, Lee Ann T Bennett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00061.2004"}], "href": "https://doi.org/10.1152/ajpheart.00061.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15165988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15165988"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Massimiliano Ruscica, Elena Dozio, Stéphane Boghossian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2005-0925"}], "href": "https://doi.org/10.1210/en.2005-0925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16339211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16339211"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "J Salomon, E Baran "}, {"type": "b", "children": [{"type": "t", "text": "The role of selected neuropeptides in pathogenesis of atopic dermatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Eur Acad Dermatol Venereol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1468-3083.2007.02399.x"}], "href": "https://doi.org/10.1111/j.1468-3083.2007.02399.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18211417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18211417"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Svati H Shah, Neil J Freedman, Lisheng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1000318"}], "href": "https://doi.org/10.1371/journal.pgen.1000318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19119412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19119412"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Karim Abid, Bertrand Rochat, Paul-Gerhard Lassahn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.035253"}], "href": "https://doi.org/10.1074/jbc.M109.035253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19620246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19620246"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "C Lu, L Everhart, J Tilan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.301"}], "href": "https://doi.org/10.1038/onc.2010.301"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20676138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20676138"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Nicoletta Croce, Vincenzo Dinallo, Valerio Ricci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurodegener Dis (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000323468"}], "href": "https://doi.org/10.1159/000323468"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21346312"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21346312"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Florim Cuculi, Neil Herring, Alberto R De Caterina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Heart (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/heartjnl-2012-303443"}], "href": "https://doi.org/10.1136/heartjnl-2012-303443"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23403409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23403409"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Satoshi Goto, Toshitaka Kawarai, Ryoma Morigaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awt084"}], "href": "https://doi.org/10.1093/brain/awt084"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23599389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23599389"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Brigitta Buttari, Elisabetta Profumo, Giacomo Domenici, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a Th2 polarization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.13-243485"}], "href": "https://doi.org/10.1096/fj.13-243485"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24699455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24699455"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Naresh C Laddha, Mitesh Dwivedi, Mohmmad Shoab Mansuri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0107020"}], "href": "https://doi.org/10.1371/journal.pone.0107020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25221996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25221996"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Anette Kaiser, Paul Müller, Tristan Zellmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unwinding of the C-Terminal Residues of Neuropeptide Y is critical for Y₂ Receptor Binding and Activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Angew Chem Int Ed Engl (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/anie.201411688"}], "href": "https://doi.org/10.1002/anie.201411688"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25924821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25924821"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Marta Diaz-delCastillo, David P D Woldbye, Anne Marie Heegaard "}, {"type": "b", "children": [{"type": "t", "text": "Neuropeptide Y and its Involvement in Chronic Pain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2017.08.050"}], "href": "https://doi.org/10.1016/j.neuroscience.2017.08.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28890052"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28890052"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Manish Kalla, Guoliang Hao, Nidi Tapoulal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Heart J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/eurheartj/ehz852"}], "href": "https://doi.org/10.1093/eurheartj/ehz852"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31834357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31834357"}]}]}]}
|
| Synonyms | PYY4 |
| Proteins | NPY_HUMAN |
| NCBI Gene ID | 4852 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NPY has 11,758 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 117 datasets.
Click the + buttons to view associations for NPY from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPY gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPY gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPY gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NPY gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NPY gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NPY gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NPY gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NPY gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NPY gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NPY gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPY gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NPY gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NPY gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NPY gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NPY gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NPY gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NPY gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NPY protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NPY protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing NPY protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NPY protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NPY protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPY gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NPY gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NPY gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NPY gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NPY gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with NPY gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NPY gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NPY gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NPY gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NPY gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NPY protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NPY gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NPY gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NPY gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NPY from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NPY gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NPY gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NPY gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NPY gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NPY from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NPY gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NPY gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NPY gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NPY gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NPY protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NPY protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NPY protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NPY gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NPY gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NPY gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NPY gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NPY gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NPY gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPY gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NPY gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NPY gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NPY gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NPY gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NPY gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NPY gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NPY protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NPY gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with NPY gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with NPY gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NPY gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NPY gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NPY protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NPY gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NPY gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NPY gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving NPY protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving NPY protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NPY gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NPY gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NPY gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NPY gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NPY gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NPY gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing NPY protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NPY protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NPY gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NPY gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NPY gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NPY gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NPY gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NPY gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NPY from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NPY gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NPY gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NPY protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NPY protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving NPY protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NPY protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NPY gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NPY gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NPY gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NPY gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with NPY protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| SynGO Synaptic Gene Annotations | synaptic terms associated with NPY gene from the SynGO Synaptic Gene Annotations dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NPY gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NPY gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NPY gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NPY protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NPY protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NPY protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NPY protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NPY protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NPY protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NPY protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NPY protein from the WikiPathways Pathways 2024 dataset. | |